An objective tool to measure the effect of botulinum toxin in blepharospasm and hemifacial spasm

被引:8
作者
Osaki, M. H. [1 ,2 ]
Osaki, T. H. [1 ,2 ]
Garcia, D. M. [3 ]
Osaki, T. [1 ,2 ]
Gameiro, G. [1 ]
Belfort, R., Jr. [1 ]
Cruz, A. A. V. [3 ]
机构
[1] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, SP, Brazil
[2] Osaki Clin, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo Ribeirao Preto, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto, SP, Brazil
关键词
blepharospasm; botulinum toxin; eyelid movements; eyelid spasms; hemifacial spasm; BENIGN ESSENTIAL BLEPHAROSPASM; QUALITY-OF-LIFE; CERVICAL DYSTONIA; NEUROTOXIN; EFFICACY; OUTCOMES; SAFETY; UPDATE; XEOMIN; IMPACT;
D O I
10.1111/ene.14258
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose It is challenging to assess patients with blepharospasm (BSP) and hemifacial spasm (HFS) as these patients exhibit a wide range of amplitudes of eyelid movements. In order to quantify these movements, a mathematical algorithm, i.e. Fast Fourier Transform, can be employed to convert the signal from the time domain to the frequency domain. The result of this quantification represents the energy generated during the eyelid movements. In order to objectively assess the therapeutic effects of botulinum toxin (BoNT) in these patients, we evaluated the energy generated by the upper eyelid during spontaneous eyelid movements before and after treatment. Methods A total of 39 patients with BSP and HFS were evaluated before and 30 days after receiving onabotulinum toxin A injections. A high-speed camera and micro light-emitting diodes were used to register the spontaneous eyelid movements. The result of the quantification obtained using Fast Fourier Transform permitted assessment of the activity associated with the eyelid movements. Results We studied 78 eyelids. The total energy generated during spontaneous eyelid movements was significantly reduced after treatment in the patients with BSP (P = 0.0018) and on the affected side in the patients with HFS (P = 0.0058). Conclusions The assessment of the energy generated by the upper eyelid during spontaneous eyelid movements enabled us to measure the therapeutic effects of BoNT in patients with these conditions. The use of this system could enable customized and fine adjustments to BoNT doses based on each patient's needs.
引用
收藏
页码:1487 / 1492
页数:6
相关论文
共 28 条
  • [1] Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs
    Bentivoglio, A. R.
    Fasano, A.
    Ialongo, T.
    Soleti, F.
    Lo Fermo, S.
    Albanese, A.
    [J]. NEUROTOXICITY RESEARCH, 2009, 15 (03) : 224 - 231
  • [2] Chemodenervation for the Treatment of Facial Dystonia A Report by the American Academy of Ophthalmology
    Bilyk, Jurij R.
    Yen, Michael T.
    Bradley, Elizabeth A.
    Wladis, Edward J.
    Mawn, Louise A.
    [J]. OPHTHALMOLOGY, 2018, 125 (09) : 1459 - 1467
  • [3] Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection
    Casse, Guillaume
    Adenis, Jean-Paul
    Sauvage, Jean-Pierre
    Robert, Pierre-Yves
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (09) : 1307 - 1314
  • [4] Botulinum toxin A treatment for primary hemifacial spasm -: A 10-year multicenter study
    Defazio, G
    Abbruzzese, G
    Girlanda, P
    Vacca, L
    Currà, A
    De Salvia, R
    Marchese, R
    Raineri, R
    Roselli, F
    Livrea, P
    Berardelli, A
    [J]. ARCHIVES OF NEUROLOGY, 2002, 59 (03) : 418 - 420
  • [5] Can the Jankovic-assessment be used as an alternative to electromyography? A cross-sectional study on facial dystonia patients treated with Botulinum toxin
    Di Stadio, Arianna
    Dipietro, Laura
    Gambacorta, Valeria
    Cristi, Maria Cristina
    Faralli, Mario
    della Volpe, Antonio
    Ricci, Giampietro
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2019, 40 (06)
  • [6] TREATMENT OF BLEPHAROSPASM WITH BOTULINUM TOXIN - A PRELIMINARY-REPORT
    FRUEH, BR
    FELT, DP
    WOJNO, TH
    MUSCH, DC
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (10) : 1464 - 1468
  • [7] Treatment of Blepharospasm/Hemifacial Spasm
    Green, Kemar E.
    Rastall, David
    Eggenberger, Eric
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (11)
  • [8] Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
    Hallett, Mark
    Albanese, Alberto
    Dressler, Dirk
    Segal, Karen R.
    Simpson, David M.
    Daniel Truong
    Jankovic, Joseph
    [J]. TOXICON, 2013, 67 : 94 - 114
  • [9] BOTULINUM-A TOXIN FOR CRANIAL-CERVICAL DYSTONIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    JANKOVIC, J
    ORMAN, J
    [J]. NEUROLOGY, 1987, 37 (04) : 616 - 623
  • [10] Efficacy and Safety of IncobotulinumtoxinA (NT 201, Xeomin) in the Treatment of Blepharospasm-A Randomized Trial
    Jankovic, Joseph
    Comella, Cynthia
    Hanschmann, Angelika
    Grafe, Susanne
    [J]. MOVEMENT DISORDERS, 2011, 26 (08) : 1521 - 1528